GLPwatch
Adlyxin for Gastroparesis
lixisenatide · Investigational / off-label
Last updated 2026-05-28 15:46 UTCAdlyxin (lixisenatide) is not FDA-approved for gastroparesis, and any use for this condition is off-label or investigational. The listed research examines lixisenatide's effects on gastric emptying but does not establish its efficacy or safety for treating gastroparesis.
AI summary of the sources below.
| Drug | Adlyxin (lixisenatide) |
|---|---|
| Condition | Gastroparesis |
| Approval status | Investigational / off-label |
| Research papers | 2 |
Adlyxin is not FDA-approved for gastroparesis; the research below reflects investigational or off-label study only.